SK
Sowmit Kumar Sinha
About Sowmit Kumar Sinha
Data last updated:
Sowmit Kumar Sinha is a Director at Kosido Pharma Private Limited (since 2021). The companies operate in Healthcare. Kosido Pharma Private Limited reported revenue of ₹7.4 Lakh (FY 2025). Earlier, Sowmit Kumar Sinha was a Director at Twenty First Century Devcons Inc. Private Limited (from 2007).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jul 2021 | 2021 | ₹7.4 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Sep 2007 | 2007 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sowmit Kumar Sinha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bishnu Sing Koner | 09197711 | Kosido Pharma Private Limited | Director |
| Ravi Dokania | 09197712 | Kosido Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sowmit Kumar Sinha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sowmit Kumar Sinha
Sowmit Kumar Sinha currently holds 1 directorship: Kosido Pharma Private Limited (Director, since 01 Jul 2021, revenue ₹7.4 Lakh (FY 2025)).
Sowmit Kumar Sinha was first appointed on 17 Sep 2007 as Director at Twenty First Century Devcons Inc. Private Limited. The most recent appointment on record is 01 Jul 2021 at Kosido Pharma Private Limited.
Sowmit Kumar Sinha held 1 earlier board appointment: Twenty First Century Devcons Inc. Private Limited (Director, from 17 Sep 2007).
The current boards of Sowmit Kumar Sinha's companies include Bishnu Sing Koner (Kosido Pharma Private Limited), Ravi Dokania (Kosido Pharma Private Limited).